MicroPort Scientific (MicroPort Scientific) Long-Term Capital Lease Obligation : $85.3 Mil (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is MicroPort Scientific Long-Term Capital Lease Obligation?

MicroPort Scientific's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was $85.3 Mil.

MicroPort Scientific's quarterly Long-Term Capital Lease Obligation declined from Dec. 2022 ($124.4 Mil) to Jun. 2023 ($103.8 Mil) and declined from Jun. 2023 ($103.8 Mil) to Dec. 2023 ($85.3 Mil).

MicroPort Scientific's annual Long-Term Capital Lease Obligation declined from Dec. 2021 ($168.4 Mil) to Dec. 2022 ($124.4 Mil) and declined from Dec. 2022 ($124.4 Mil) to Dec. 2023 ($85.3 Mil).

MicroPort Scientific Long-Term Capital Lease Obligation Historical Data

The historical data trend for MicroPort Scientific's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort Scientific Long-Term Capital Lease Obligation Chart

MicroPort Scientific Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

44.53

42.77

168.44

124.37

85.33

MicroPort Scientific Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															168.44	137.45	124.37	103.83	85.33

MicroPort Scientific (OTCPK:MCRPF) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

MicroPort Scientific Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of MicroPort Scientific's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

MicroPort Scientific (MicroPort Scientific) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort Scientific Corp (OTCPK:MCRPF) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

00853:Hong Kong MSK:Germany

Address

1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Shanghai, CHN, 201203

Website

https://www.microport.com

MicroPort Scientific Corp develops & markets medical devices in eight segments. Cardiovascular devices business: sales, manufacture, R&D of cardiovascular devices like drug-eluting stents. Orthopedics devices business: sales, manufacture, R&D of orthopedics devices. CRM business: sales, manufacture, R&D of cardiac rhythm management devices. Endovascular & peripheral vascular devices business: sales, manufacture, R&D of endovascular & peripheral vascular devices. Neurovascular devices business: sales, manufacture, R&D of neurovascular devices. Heart valve business: sales, manufacture, R&D of heart valve devices. Surgical robot business: sales, manufacture, R&D of surgical robot devices. Surgical devices business: sales, manufacture, R&D of surgical devices. The key revenue is from The PRC.

MicroPort Scientific (MicroPort Scientific) Headlines

From GuruFocus

Firehawk® Clinical Data From The TARGET AC European Clinical Trial Has Been Accepted For Publication In The Prestigious Medical Journal The Lancet

By PRNewswire PRNewswire • 09-04-2018

MicroPort Orthopedics and Medacta Agree to Settlement on Patent Claims

By PRNewswire PRNewswire • 07-14-2021